Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
This study is a multicenter, open-label, postmarketing surveillance study. The substudy will collect information on BMD in adolescents and young adults with GHD or Turner syndrome who are completing GH treatment for statural indications.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Bone Mineral Density in Adolescent Subjects With Growth Hormone Deficiency Who Are Completing Treatment With Nutropin AQ, Nutropin, or Protropin in the National Cooperative Growth Study (NCGS)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00097526
|Study Director:||Barbara Lippe, M.D.||Genentech, Inc.|